Home » Topics » BioWorld Science

BioWorld Science
RSS

Bayer patents novel IRAK-4 inhibitors

April 18, 2018

Pfizer launches Besponsa in Japan

April 18, 2018

Mironid identifies novel PDE4 activators

April 18, 2018

Mission Therapeutics divulges new USP30 inhibitors

April 18, 2018

GlaxoSmithKline patents novel TrpV4 antagonists

April 18, 2018

BioAtla describes activity of anti-ROR2 antibody-drug conjugate BA-3021

April 18, 2018

Asahi Kasei Pharma initates phase III study of isavuconazole for deep-seated mycosis

April 18, 2018

FDA grants orphan drug designation to KL-1333 for inherited mitochondrial respiratory chain diseases

April 18, 2018

EPL-1410 demonstrates potential as immune-oncology therapeutic in preclinical models

April 18, 2018

Anavex to initiate phase II trial of ANAVEX2-73 in Parkinson's disease dementia

April 18, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...